Jan Desmyter
- Infectious Diseases top 0.1%
- Virology top 0.05%
- Epidemiology top 0.5%
- Immunology top 1%
- Molecular Biology top 5%
- Co-authors
- Erik De ClercqRudi PauwelsDominique ScholsMasanori BabaJan BalzariniAnne–Mieke VandammePiet HerdewijnRobert Snoeck
- Topics
- HIV Research and Treatment (64 papers)HIV/AIDS drug development and treatment (61 papers)T-cell and Retrovirus Studies (44 papers)
- Partner nations
- BelgiumUnited StatesDemocratic Republic of the Congo
In The Last Decade
Jan Desmyter
206 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Infectious Diseases 4.9k
- Virology 4.1k
- Epidemiology 2.9k
- Immunology 2.3k
- Molecular Biology 2.0k
Countries citing papers authored by Jan Desmyter
This map shows the geographic impact of Jan Desmyter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Desmyter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Desmyter more than expected).
Fields of papers citing papers by Jan Desmyter
This network shows the impact of papers produced by Jan Desmyter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Desmyter. The network helps show where Jan Desmyter may publish in the future.
Co-authorship network of co-authors of Jan Desmyter
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Desmyter. A scholar is included among the top collaborators of Jan Desmyter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Desmyter. Jan Desmyter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | Baseline resistance is significantly associated with long-term therapy response, especially in non-adherent patients | 3 |
| 3 | 76 | |
| 4 | 11 | |
| 5 | 78 | |
| 6 | 31 | |
| 7 | 92 | |
| 8 | 20 | |
| 9 | PHYLOGENETIC ANALYSIS OF A DIVERGENT T-LYMPHOTROPIC VIRUS FROM A PYGMY CHIMPANZEE SUPPORTS AN AFRICAN ORIGIN FOR THE HTLV/STLV GROUP OF VIRUSES | 1 |
| 10 | A PRIMATE T-LYMPHOTROPIC VIRUS, PTLV-L, DIFFERENT FROM HTLV-I AND HTLV-II IN A WILD-CAUGHT BABOON | 10 |
| 11 | PRIMATE T-LYMPHOTROPIC VIRUS TYPE-I LTR SEQUENCE VARIATION AND ITS PHYLOGENETIC ANALYSIS - COMPATIBILITY WITH AN AFRICAN ORIGIN OF PTLV-I | 13 |
| 12 | 36 | |
| 13 | 44 | |
| 14 | 75 | |
| 15 | 2 | |
| 16 | 48 | |
| 17 | Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesbreakdown → | 673 |
| 18 | 173 | |
| 19 | Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium. | 12 |
| 20 | 33 |
About Jan Desmyter
Jan Desmyter is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 207 papers that have together received 10.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (64 papers), HIV/AIDS drug development and treatment (61 papers) and T-cell and Retrovirus Studies (44 papers). The work is most often cited by research in Virology (4.1k citations), Infectious Diseases (4.9k citations) and Hepatology (1.0k citations). Jan Desmyter has collaborated with scholars based in Belgium, United States and Democratic Republic of the Congo. Frequent co-authors include Erik De Clercq, Rudi Pauwels, Dominique Schols, Masanori Baba, Jan Balzarini, Anne–Mieke Vandamme, Piet Herdewijn, Robert Snoeck, Patrick Goubau and William E. Rawls. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.